tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Oppenheimer healthcare analysts hold an analyst/industry conference call
PremiumThe FlyOppenheimer healthcare analysts hold an analyst/industry conference call
1M ago
Avalo Therapeutics management to meet with Piper Sandler
Premium
The Fly
Avalo Therapeutics management to meet with Piper Sandler
1M ago
Avalo Therapeutics Highlights AVTX-009 Potential in New Presentation
Premium
Company Announcements
Avalo Therapeutics Highlights AVTX-009 Potential in New Presentation
2M ago
Avalo Therapeutics price target raised to $25 from $15 at H.C. Wainwright
PremiumThe FlyAvalo Therapeutics price target raised to $25 from $15 at H.C. Wainwright
2M ago
Oppenheimer buyers of Avalo Therapeutics ahead of lutikizumab data
Premium
The Fly
Oppenheimer buyers of Avalo Therapeutics ahead of lutikizumab data
2M ago
3 Best Stocks to Buy Now, 9/12/2025, According to Top Analysts
Premium
Market News
3 Best Stocks to Buy Now, 9/12/2025, According to Top Analysts
2M ago
Avalo Therapeutics initiated with an Overweight at Cantor Fitzgerald
PremiumThe FlyAvalo Therapeutics initiated with an Overweight at Cantor Fitzgerald
3M ago
Avalo Therapeutics Reports Q2 2025 Financial Results
Premium
Company Announcements
Avalo Therapeutics Reports Q2 2025 Financial Results
4M ago
Avalo Therapeutics: Promising Phase 2 Trial and Market Opportunities Drive Buy Rating
Premium
Ratings
Avalo Therapeutics: Promising Phase 2 Trial and Market Opportunities Drive Buy Rating
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100